|
|
Volumn 6, Issue 31, 2015, Pages 30451-30452
|
|
DOT1L: A new therapeutic target for aggressive breast cancer
a
a
|
|
Author keywords
Breast cancer; Chromosome Section; DOT1L; EMT; Histone methylation
|
|
Indexed keywords
ACYLTRANSFERASE;
DISRUPTOR OF TELOMERIC SILENCING 1 LIKE PROTEIN;
DISRUPTOR OF TELOMERIC SILENCING 1 LIKE PROTEIN INHIBITOR;
HISTONE H3;
HISTONE LYSINE METHYLTRANSFERASE INHIBITOR;
HISTONE METHYLTRANSFERASE;
LYSINE;
MYC PROTEIN;
PINOMETOSTAT;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR SNAIL;
TRANSCRIPTION FACTOR ZEB1;
TRANSCRIPTION FACTOR ZEB2;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
DOT1L PROTEIN, HUMAN;
EPZ-5676;
HISTONE;
METHYLTRANSFERASE;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
BREAST CANCER;
BREAST CANCER CELL LINE;
CANCER PROGNOSIS;
CANCER STEM CELL;
CLINICAL TRIAL (TOPIC);
DRUG TARGETING;
EDITORIAL;
EPITHELIAL MESENCHYMAL TRANSITION;
HISTONE ACETYLATION;
HISTONE METHYLATION;
HUMAN;
LEUKEMIA;
METASTASIS INHIBITION;
MIGRATION INHIBITION;
NONHUMAN;
PROTEIN BINDING;
PROTEIN DEPLETION;
TRANSCRIPTION INITIATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BREAST NEOPLASMS;
FEMALE;
GENETICS;
METABOLISM;
METHYLATION;
MOUSE;
PHYSIOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZIMIDAZOLES;
BREAST NEOPLASMS;
EPITHELIAL-MESENCHYMAL TRANSITION;
FEMALE;
HISTONES;
HUMANS;
LEUKEMIA;
METHYLATION;
METHYLTRANSFERASES;
MICE;
NEOPLASTIC STEM CELLS;
TRANSCRIPTIONAL ACTIVATION;
|
|
EID: 84945538337
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.5860 Document Type: Editorial |
|
Times cited : (20)
|
|
References (7)
|
